Little Green Pharma (ASX:LGP) share price leaps 7% on revenue growth

Patient demand for medicinal cannabis products has grown in Australia.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Little Green Pharma Ltd (ASX: LGP) share price is well in the green today, currently up 3.7% at 70 cents after soaring 7% higher this morning.

Below we take a look at the ASX cannabis share's quarterly results that look to be driving investor interest.

What did the quarterly update reveal?

Little Green Pharma's share price is soaring after the company reported "strong revenue growth" and a record month of sales for September.

Unaudited revenue came in at $3.18 million while the company reported an all-time monthly high of $1.39 million in sales for September.

As at 30 September, Little Green Pharma had a cash position of $29.1 million. It reported that, "Cash receipts lagged sales as debtors missed the cut-off for the month, with over $900,000 being received in the first few days of the current quarter."

Growth and acquisitions

The Little Green Pharma share price may also be getting a boost from the strong growth in its Australian market. The company reported 4,580 new patients, a 39% quarter-on-quarter increase. And 110 new prescribers represented an increase of 46% from new prescribers coming on board during the previous quarter.

During the quarter, the company also completed its $6 million acquisition of "the properties underlying its cultivation and manufacturing facilities in Western Australia, as well as the two adjoining properties".

Little Green Pharma said it was continuing to focus on European commercial sales. In line with that, the company has started integration of its Danish facility.

Atop its cannabis offering, the company also is progressing with its psychedelics business. In September, the Western Australian State Health department revised Little Green Pharma's Schedule 9 licence "to permit the supply of psilocybin".

Little Green Pharma share price snapshot

Over the past 12 months, the Little Green Pharma share price has rocketed 105.8%. That compares to a gain of 24% posted by the All Ordinaries Index (ASX: XAO) over that same time.

Little Green Pharma's shares have been trading relatively flat over the past month.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Cannabis Shares

Man in the green house growing medical cannabis
Cannabis Shares

ASX cannabis stocks eyeing $1 billion domestic market

Legal cannabis use is soaring in Australia.

Read more »

two men in formal business clothing closely inspect a bud from a cannabis crop.
Cannabis Shares

2 ASX cannabis shares with big news today

What's going on with these pot stocks today? Let's find out.

Read more »

A man in a horse head mask and suit jumps for joy on a beach.
Cannabis Shares

Could ASX cannabis shares be set for a smoking hot rebound?

ASX cannabis stocks could be set for a strong finish to 2024.

Read more »

Man in a cannabis greenhouse looks unhappy and puts his thumb down.
Cannabis Shares

Why are these 2 ASX cannabis stocks sputtering today?

Up 174% in 2023, this ASX cannabis share is giving back some more of its gains today.

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Cannabis Shares

Guess which ASX cannabis share is crashing 36% following an FDA blow

Rookie mistake: This cannabis share just missed out on FDA approval for a simple reason.

Read more »

A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
Cannabis Shares

Could ASX cannabis shares be set for a resurgence?

The world's legal and medical fraternities are taking small steps forward in the medicinal cannabis movement.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Cannabis Shares

This ASX cannabis stock is up 160% since June, and it has an FDA ruling coming up!

Investors are very excited about this cannabis stock.

Read more »

two men in formal business clothing closely inspect a bud from a cannabis crop.
Cannabis Shares

Why ASX cannabis shares just jumped back into the spotlight

ASX cannabis shares operate in a nation where medical marijuana is legal but recreational use remains broadly forbidden.

Read more »